Drug Report History

Return to report

Below you will find the report version history. When a report is updated, a new version of the report is created. The report history allows you to see the changes between versions. You can select two versions of the report to compare. The fields that were changed between versions will be highlighted in yellow.

The translation of reports creates two separate versions which is why some reports may not seem to have any differences. In this case, only the language field below will be highlighted in yellow.

Version v3-EN Version v2-FR
Language English French
Date Updated 2020-05-22 2020-05-21
Drug Identification Number 02355280 02355280
Brand name SEPTA-CITALOPRAM SEPTA-CITALOPRAM
Common or Proper name CITALOPRAM HYDROBROMIDE CITALOPRAM HYDROBROMIDE
Company Name SEPTA PHARMACEUTICALS INC SEPTA PHARMACEUTICALS INC
Ingredients CITALOPRAM CITALOPRAM
Strength(s) 40MG 40MG
Dosage form(s) TABLET TABLET
Route of administration ORAL ORAL ORAL ORAL
Packaging size 100s 100s
ATC code N06AB N06AB
ATC description ANTIDEPRESSANTS ANTIDEPRESSANTS
Reason for shortage Other (Please describe in comments) Other (Please describe in comments)
Anticipated start date
Actual start date 2020-05-21 2020-05-21
Estimated end date Unknown Unknown
Actual end date
Shortage status Actual shortage Anticipated shortage
Tier 3 Status No No
Company comments SUPPLY ISSUES SUPPLY ISSUES
Health Canada comments